Thursday, September 23, 2010
EU Pulls Plug On Glaxo's Avandia, FDA Restricts
LONDON/WASHINGTON - European officials moved to pull GlaxoSmithKline's diabetes drug Avandia off the market and U.S. authorities imposed tight restrictions over heart risks, effectively spelling the commercial end to the once-lucrative medicine.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment